Valeant to Buy Sanofi’s Dermik Skincare Unit for US$425 M
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 7 (Table of Contents)
Published: 25 Jul-2011
DOI: 10.3833/pdr.v2011.i7.1510 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Continuing the trend of big pharma divesting its non-core assets, Sanofi has agreed to sell its Dermik dermatology unit to Valeant Pharmaceuticals for approximately US$425 M in order to focus on its key growth platforms...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS